More than half of Zionexa’s team works in R&D everyday, in order to develop innovative molecular imaging in-vivo biomarkers that will help clinicians to stratify patients and therapies, i.e. find the right treatment, for the right patient, at the right time.

Solid, innovative in-vivo biomarkers pipeline

Transforming oncology

Contact us to find out more about in-vivo biomarkers in molecular imaging